Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-07

Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing azilsartan medoxomil with chlorthalidone against olmesartan medoxomil with hydrochlorothiazide shows comparative efficacy and safety in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azilsartan medoxomil (azilsartan medoxomil)
  • Chlorthalidone (chlorthalidone)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-02-07